The prognostic value of MR-proadrenomedullin in patients with acute coronary syndrome complicated by cardiogenic shock

References

• Artunc, F., et al., 2014. Plasma concentrations of the vasoactive peptide fragments mid-regional pro-adrenomedullin, C-terminal pro-endothelin 1 and copeptin in hemodialysis patients: associated factors and prediction of mortality. PLoS One, 229, e86148.
   Google Scholar
• BRAHMS Kryptor. Automated immunofluorescent assay for the determination of midregional pro-adrenomedullin (MR-proADM) in human EDTA plasma. [Online] Available from: www.radmed.com.tr.
   Google Scholar
• Brouwers, F.P., et al., 2012. Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population. Heart, 98, 1348–1353.
   PubMed Web of Science ®Google Scholar
• Chan, D. and Ng, L. 2010. Biomarkers in acute myocardial infarction. BMC medicine, 8, 34.
   PubMed Web of Science ®Google Scholar
• Christ-Crain, M. and Muller, B. 2007. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. European respiratory journal, 30, 556–573.
   PubMed Web of Science ®Google Scholar
• Dhillon, O., et al., 2010. Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardialinfarction. The LAMP (Leicaster Acute Myocardial Infarction Peptide) II study. Journal of American college cardiology, 56, 125–133.
   PubMed Web of Science ®Google Scholar
• Dieplinger, B., et al., 2009. Pro-a-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study. Kidney International, 75, 408–414.
   PubMed Web of Science ®Google Scholar
• Funke-Kaiser, A., et al., (2014). Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: The LIPID study. International journal of cardiology, 172, 411–418.
   PubMed Web of Science ®Google Scholar
• Funke-Kaiser, A., et al., 2014. Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort. Annals of medicine, 46, 155–162.
   PubMed Web of Science ®Google Scholar
• Gegenhuber, A., et al., 2007. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure. Journal of cardiology fail, 13, 42–49.
   PubMed Web of Science ®Google Scholar
• Haaf, P., et al., 2013. Mid-regional pro-adrenomedullin in the early evaluation of acute chest pain patients. International journal of cardiology, 168, 1048–1055.
   PubMed Web of Science ®Google Scholar
• Ichiki, Y., et al., 1994. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS letters, 338, 6–10.
   PubMed Web of Science ®Google Scholar
• Ishimitsu, T., et al., 1994. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. Journal of clinical investigation, 94, 2158–2161.
   PubMed Web of Science ®Google Scholar
• Jougasaki, M. and Burnett, J. Jr. 2000. Adrenomedullin: potential in physiology and pathophysiology. Minireview life sciences, 66, 855–872.
   PubMed Web of Science ®Google Scholar
• Katayama, T., et al., 2004. Evaluation of neurohumoral activation (adrenomedullin, BNP, catecholamines, etc.) in patients with acute myocardial infarction. Internal medicine, 43, 1015–1022.
   PubMed Web of Science ®Google Scholar
• Katayama, T., et al., 2005. Predictors of mortality in patients with acute myoacrdial infarction and cardiogenic shock. Circulation journal, 69, 83–88.
   PubMed Web of Science ®Google Scholar
• Khan, S., et al., 2007. Prognostic value of Midregional Pro-Adrenomedullin in patients with acute myocardial infarction. The LAMP (Leicaster Acute Myocardial Infarction Peptide) Study. JACC, 49, 1525–1532.
   Web of Science ®Google Scholar
• Kitamura, K., et al., 1993. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochemical biophysical research communication, 192, 553–560.
   PubMed Web of Science ®Google Scholar
• Klip, I.T., et al., 2011. Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction. Heart, 97, 892–898.
   PubMed Web of Science ®Google Scholar
• Legrand, M., et al., 2015. Failure of renal biomarkers to predict worsening renal function in high-risk patients presenting with oliguria. Intensive care medicine, 41, 68–76.
   PubMed Web of Science ®Google Scholar
• Lippton, H., et al., 1994. Adrenomedullin dilates the pulmonary vascular bed in vivo. Journal of applied physiology, 76, 2154–2156.
   PubMed Web of Science ®Google Scholar
• Maisel, A., et al., 2010. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Journal of American college cardiology, 55, 2062–2076.
   PubMed Web of Science ®Google Scholar
• Miyao, Y., et al., 1998. Increased plasma adrenomedullin levels in patients with acute myocardial infarction. Heart, 79, 39–44.
   PubMed Web of Science ®Google Scholar
• Morgenthaler, N.G., Struck, J., Alonso, C., and Bergman, A. 2005. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clinical chemistry, 51, 1823–1829.
   PubMed Web of Science ®Google Scholar
• Moriyama, N., et al., 2016. Early development of acute kidney injury is an independent predictor of in-hospital mortality in patients with acute myocardial infarction. Journal cardiology, doi: 10.1016/j.jjcc.2016.01.001 [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Nagaya, N., et al., 2002. Intravenous adrenomedullin in myocardial function and energy metabolism in patients after myocardial infarction. Journal of cardiovascular pharmacology, 39, 754–760.
   PubMed Web of Science ®Google Scholar
• Neumann, J., et al., 2013. Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease. Atherosclerosis, 228, 451–459.
   PubMed Web of Science ®Google Scholar
• Nishikimi, T., et al., 2003. Cardioprotective effect of adrenomedullin in heart failure. Hypertension research, 26, 121–127.
   Web of Science ®Google Scholar
• Peacock, W.F. 2014. Novel biomarkers in acute heart failure: MR-pro-adrenomedullin. Clinical chemistry laboratory medicine, 52, 1433–1435.
   PubMed Web of Science ®Google Scholar
• Sugo, S., et al., 1994. Endothelial cells actively synthesize and secrete adrenomedullin. Biochemical biophysical research communication, 201, 1160–1166.
   PubMed Web of Science ®Google Scholar
• Suzuki, Y., et al., 2013. Significant decrease in plasma midregional proadrenomedullin level in patients with end-stage renal disease after living kidney transplantation. Peptides, 43, 102–104.
   PubMed Web of Science ®Google Scholar
• The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). 2012. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European heart journal, 33, 2569–2619.
   PubMed Web of Science ®Google Scholar
• Thygsen, K., et al., (2012). Third universal definition of myocardial infarction. European heart journal, 33, 2551–2567.
   PubMed Web of Science ®Google Scholar
• Tsuruda, T, et al., 1998. Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes. Hypertension, 31, 505–510.
   PubMed Web of Science ®Google Scholar
• von Haehlig, S., et al., 2010. Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure. European journal of heart fail, 12, 484–491.
   PubMed Web of Science ®Google Scholar
• Wild, P.S., et al., 2012. Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study. Clinical chemistry, 58, 226–236.
   PubMed Web of Science ®Google Scholar
• Wong, H.K., Tang, F., Cheung, T.T., and Cheung, B.M.Y. 2014. Adrenomedullin and diabetes. World journal of diabetes, 5, 364–371.
   PubMedGoogle Scholar